ZA200606554B - Pharmaceutical composition for oral application and method for preparing thereof - Google Patents

Pharmaceutical composition for oral application and method for preparing thereof

Info

Publication number
ZA200606554B
ZA200606554B ZA200606554A ZA200606554A ZA200606554B ZA 200606554 B ZA200606554 B ZA 200606554B ZA 200606554 A ZA200606554 A ZA 200606554A ZA 200606554 A ZA200606554 A ZA 200606554A ZA 200606554 B ZA200606554 B ZA 200606554B
Authority
ZA
South Africa
Prior art keywords
preparing
pharmaceutical composition
oral application
composition
oral
Prior art date
Application number
ZA200606554A
Other languages
English (en)
Inventor
Mattern Claudia
Pieper Wilfried
Original Assignee
Cum Pharma Consulting Anstalt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cum Pharma Consulting Anstalt filed Critical Cum Pharma Consulting Anstalt
Publication of ZA200606554B publication Critical patent/ZA200606554B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
ZA200606554A 2004-02-20 2005-02-09 Pharmaceutical composition for oral application and method for preparing thereof ZA200606554B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04003906A EP1566173B1 (en) 2004-02-20 2004-02-20 Pharmaceutical composition for oral application and method for preparing thereof

Publications (1)

Publication Number Publication Date
ZA200606554B true ZA200606554B (en) 2008-05-28

Family

ID=34707350

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200606554A ZA200606554B (en) 2004-02-20 2005-02-09 Pharmaceutical composition for oral application and method for preparing thereof

Country Status (16)

Country Link
US (1) US7767228B2 (ru)
EP (2) EP1566173B1 (ru)
JP (1) JP4800225B2 (ru)
AT (1) ATE336230T1 (ru)
AU (1) AU2005215108B2 (ru)
BR (1) BRPI0507848A (ru)
CA (1) CA2554640C (ru)
DE (1) DE602004001969T2 (ru)
DK (1) DK1566173T3 (ru)
ES (1) ES2271714T3 (ru)
NO (1) NO20064240L (ru)
PT (1) PT1566173E (ru)
RU (1) RU2342936C2 (ru)
SI (1) SI1566173T1 (ru)
WO (1) WO2005079759A2 (ru)
ZA (1) ZA200606554B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101257892B (zh) * 2005-05-18 2013-01-02 达沃尔泰拉公司 吸附剂的结肠递送
US8048413B2 (en) * 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
UY31410A1 (es) * 2007-10-30 2009-05-29 Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado
JP2010106007A (ja) * 2008-08-14 2010-05-13 Sony Corp 薬剤徐放剤、吸着剤、機能性食品、マスク及び吸着シート
PE20120182A1 (es) * 2008-12-05 2012-02-24 Bayer Ip Gmbh Extruidos con sustancias activas con forma de agujas
HU231017B1 (hu) 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk
RU2514056C2 (ru) * 2012-08-21 2014-04-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ инкапсуляции фенбендазола
JP6472341B2 (ja) * 2015-06-26 2019-02-20 株式会社トーヨー技術研究所 固形状の魚類用経口投与薬剤、当該薬剤を含む養魚用飼料、および当該薬剤を魚に投与する方法
CA3191671A1 (en) 2020-09-04 2022-03-10 Elanco Us Inc. Palatable formulations
CN117881425A (zh) 2021-08-31 2024-04-12 株式会社东洋技术研究所 水栖动物用经口给药药剂
JP7368042B2 (ja) 2021-08-31 2023-10-24 株式会社トーヨー技術研究所 水棲動物用経口投与薬剤

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1879601A (en) * 1926-03-13 1932-09-27 Merck & Co Inc Iodine composition
BE634024A (ru) * 1962-06-25
US3709833A (en) * 1970-08-21 1973-01-09 Owens Illinois Inc Process for preparing high purity silicon oxide porous beads doped with small quantities of other oxides
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates
SU1465052A1 (ru) * 1985-06-10 1989-03-15 Институт Зоологии Ан Казсср Способ профилактики и лечени гельминтозов животных
US5013716A (en) * 1988-10-28 1991-05-07 Warner-Lambert Company Unpleasant taste masking compositions and methods for preparing same
JPH05238930A (ja) * 1992-02-28 1993-09-17 Eisai Co Ltd 持続性薬剤
IL116674A (en) * 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5827497A (en) * 1996-08-14 1998-10-27 Mayo Foundation For Medical Education And Research Charcoal-radionuclide agents for measurement of gastrointestinal transit
WO1998053802A1 (en) * 1997-05-30 1998-12-03 Laboratorios Phoenix U.S.A., Inc. Multi-layered osmotic device
DE19726412A1 (de) * 1997-06-21 1998-12-24 Merck Patent Gmbh Implantatmaterial mit einer Träger-Wirkstoff-Kombination
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
JP3834732B2 (ja) * 1998-08-05 2006-10-18 株式会社ロッテ チューインガム
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
US6491949B2 (en) * 2000-01-14 2002-12-10 Osmotica Corp. Osmotic device within an osmotic device
EP1362583A1 (de) * 2002-05-15 2003-11-19 CUM Taste Masking AG Verfahren zur Geschmacksmaskierung von Substanzen durch Mikroverkapselung
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
KR101030735B1 (ko) * 2002-08-13 2011-04-26 인터벳 인터내셔널 비.브이. 첨가제를 전달하는 조성물 및 전달 방법
WO2004040679A1 (ja) * 2002-10-31 2004-05-13 Matsushita Electric Industrial Co., Ltd. 多孔電極およびそれを用いた電気化学素子

Also Published As

Publication number Publication date
NO20064240L (no) 2006-11-20
US20050186272A1 (en) 2005-08-25
CA2554640A1 (en) 2005-09-01
AU2005215108A1 (en) 2005-09-01
SI1566173T1 (sl) 2006-12-31
DE602004001969T2 (de) 2007-03-15
RU2006133543A (ru) 2008-04-10
AU2005215108B2 (en) 2010-10-07
CA2554640C (en) 2011-04-12
EP1566173A1 (en) 2005-08-24
ATE336230T1 (de) 2006-09-15
JP4800225B2 (ja) 2011-10-26
ES2271714T3 (es) 2007-04-16
JP2007523108A (ja) 2007-08-16
DK1566173T3 (da) 2006-12-27
DE602004001969D1 (de) 2006-09-28
PT1566173E (pt) 2006-12-29
EP1715850A2 (en) 2006-11-02
WO2005079759A3 (en) 2006-06-15
BRPI0507848A (pt) 2007-07-10
US7767228B2 (en) 2010-08-03
RU2342936C2 (ru) 2009-01-10
EP1566173B1 (en) 2006-08-16
WO2005079759A2 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
ZA200606554B (en) Pharmaceutical composition for oral application and method for preparing thereof
MXPA04004464A (es) Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
EE200300373A (et) Meetod kamptotetsiini analoogide sünteesimiseks kasutatavate ühendite valmistamiseks ning kamptotetsiini analoogide terviksüntees
BR0308452A (pt) composições farmacêuticas e métodos de preparação de composição farmacêutica
NO20074086L (no) Fremgangsmate for fremstilling av lansoprazol
EP1726299A3 (en) Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
EG24124A (en) Pharmaceutical compositions for the treatment of type-II diabetes mellitus
HK1076605A1 (en) Formulations
EP1786467A4 (en) METHOD FOR IMPROVING THE ABSORPTION OF TRANSMUCOSUS FORMATIONS ADMINISTERED THROUGH
HK1155146A1 (zh) 作為藥物活性劑的茚衍生物
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
ATE521338T1 (de) Pharmazeutische formulierungen mit metformin und einem fibrat und herstellungsverfahren dafür
WO2008154083A3 (en) Compounds, compositions and methods for the treatment of synucleinopathies
MX2008001560A (es) Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2328496T3 (es) Compuestos de 1,4,8-triaza-espiro(4,5)decan-2-ona sustituidos.
EA200701687A1 (ru) Гидрохлорид аморфного лерканидипина
WO2004100865A3 (en) New benzimidazole derivatives
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
AU2003230189A1 (en) Oral controlled release pharmaceutical composition containing metaxalone as active agent
HK1077232A1 (en) Medicinal composition for mitigating blood lipid or lowering blood homocystein
EP1944027A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF NEPHRITIS AND METHOD FOR PRODUCING THE SAME
TW200640933A (en) Anthelmintic compounds
MXPA05009686A (es) Composicion farmaceutica comprendiendo acido 5-metil-2-(2'-cloro-6'-fluoroanilino) fenilacetico.
WO2005120584A3 (en) Radiolabeled arylsulfonyl compounds and uses thereof
IL172758A0 (en) Pharmaceutical compositions containing balaglitazone and methods for the preparation thereof